Education
About Us
Working with TipRanks
Follow Us
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 258.00M | $ 117.00M | $ 112.00M | $ 383.00M | $ 78.00M |
| Gross Profit | $ 258.00M | $ 117.00M | $ 112.00M | $ 383.00M | $ 78.00M |
| Operating Income | $ -330.00M | $ -340.00M | $ -280.00M | $ 54.00M | $ -124.00M |
| EBITDA | $ -269.00M | $ -291.00M | $ -258.00M | $ 59.00M | $ -120.00M |
| Net Income | $ -283.00M | $ -307.00M | $ -267.00M | $ 53.00M | $ -123.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 978.00M | $ 759.00M | $ 1.14B | $ 681.30M | $ 735.09M |
| Total Assets | $ 1.15B | $ 1.09B | $ 1.34B | $ 1.59B | $ 772.29M |
| Total Debt | $ 60.00M | $ 11.00M | $ 120.00M | $ 116.89M | $ 15.24M |
| Net Debt | $ -90.00M | $ -116.00M | $ -86.00M | $ -31.03M | $ -158.17M |
| Total Liabilities | $ 665.00M | $ 633.00M | $ 688.00M | $ 750.45M | $ 269.99M |
| Stockholders' Equity | $ 485.00M | $ 462.00M | $ 657.00M | $ 841.45M | $ 502.30M |
| Cash Flow | |||||
| Free Cash Flow | $ -176.00M | $ -330.00M | $ 426.00M | $ -282.25M | $ 108.11M |
| Operating Cash Flow | $ -170.00M | $ -306.00M | $ 438.00M | $ -256.17M | $ 111.17M |
| Investing Cash Flow | $ -84.00M | $ 194.00M | $ -413.00M | $ -3.87M | $ -434.37M |
| Financing Cash Flow | $ 277.00M | $ 33.00M | $ 33.00M | $ 237.34M | $ 438.68M |